Ergogycle prototype testing for acceptability for End-stage Renal Disease

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
CIUSSS de l'Estrie - CHUS, Sherbrooke, Canada
End-stage Renal Disease+1 More
Ergogycle prototype testing for acceptability - Device
Eligibility
Any Age
All Sexes
What conditions do you have?
Select

Study Summary

This trial found that the connected ergocycle was useful and acceptable to both health professionals and patients. Ergogycle prototype testing is being done to see if it is an acceptable treatment for End-stage Renal Disease. No patients in this trial will receive a placebo. Ergogycle prototype testing has previously been approved by the FDA for a different condition.

Eligible Conditions

  • End-stage Renal Disease

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for End-stage Renal Disease

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: up to 1 hour after the exercise session for both the patients and professionals

Hour 1
Acceptability of the device

Trial Safety

Safety Progress

1 of 3

Other trials for End-stage Renal Disease

Trial Design

2 Treatment Groups

Intradialytic exercise (patients)
1 of 2
Acute care exercise (patients)
1 of 2
Experimental Treatment

20 Total Participants · 2 Treatment Groups

Primary Treatment: Ergogycle prototype testing for acceptability · No Placebo Group · N/A

Intradialytic exercise (patients)
Device
Experimental Group · 1 Intervention: Ergogycle prototype testing for acceptability · Intervention Types: Device
Acute care exercise (patients)
Device
Experimental Group · 1 Intervention: Ergogycle prototype testing for acceptability · Intervention Types: Device

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: up to 1 hour after the exercise session for both the patients and professionals
Closest Location: CIUSSS de l'Estrie - CHUS · Sherbrooke, Canada
Photo of quebec 1Photo of quebec 2Photo of quebec 3
2021First Recorded Clinical Trial
1 TrialsResearching End-stage Renal Disease
5 CompletedClinical Trials

Who is running the clinical trial?

Université de SherbrookeLead Sponsor
257 Previous Clinical Trials
68,910 Total Patients Enrolled

Eligibility Criteria

Age Any Age · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are older than 55 years.
You are physically independent outside HD or before admission (ICU) (≥ 70 on the Barthel index).

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.